| University Park Podiatry | |
|
3665 Park Pl W, Suite 200, Mishawaka, IN 46545-3566 | |
| (574) 271-1030 | |
| (574) 271-1032 |
| Full Name | University Park Podiatry |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 3665 Park Pl W, Mishawaka, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295753267 | NPI | - | NPPES |
| 200425560A | Medicaid | IN | |
| 1528065059 | Other | NPI DR SALCEDO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 07000626A (Indiana) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 07000626A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| University Park Podiatry 3665 Park Pl W, Suite 200, Mishawaka, IN 46545-3566 Ph: (574) 271-1030 | University Park Podiatry 3665 Park Pl W, Suite 200, Mishawaka, IN 46545-3566 Ph: (574) 271-1030 |
News Archive
Attention-deficit/hyperactivity disorder (ADHD) increases the risk of subsequent sexually transmitted infections (STIs) among adolescent and young adult populations by about three times, reports a study published in the January 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
The Council for Citizens Against Government Waste (CCAGW) has encouraged Congress to pass S. 852, the Fairness in Asbestos Injury Resolution Act (FAIR Act). The legislation establishes a trust fund to reimburse true victims of asbestos exposure while limiting the actions of trial lawyers.
In an effort to insure JCAHO compliance and continue its tradition of providing the highest quality of care to its young patients, the Children's Hospital of Alabama has purchased the iRISecure tissue tracking system from Mobile Aspects.
OXiGENE, a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced that an ongoing analysis of positive results reported earlier from a randomized, controlled, Phase 2/3 study of ZYBRESTAT (fosbretabulin, CA4P) were presented today at the 35th European Society of Medical Oncology (ESMO) Congress in Milan, Italy by Julie Ann Sosa, M.D., F.A.C.S., of Yale University.
› Verified 5 days ago
Dr N W Worden Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2206 Lincolnway E, Mishawaka, IN 46544 Phone: 574-258-5060 Fax: 574-258-5076 | |
Ngan T Nguyen, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 101, Mishawaka, IN 46545 Phone: 574-335-6800 Fax: 574-335-0732 | |
Cassandra Papak, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd, Ste 406, Mishawaka, IN 46545 Phone: 574-335-6500 Fax: 574-335-0772 | |
Dr. N W Worden, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2206 Lincoln Way E, Mishawaka, IN 46544 Phone: 574-258-5060 Fax: 574-258-5076 | |
Michael Salcedo, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3665 Park Pl W, Suite 200, Mishawaka, IN 46545 Phone: 574-271-1030 Fax: 574-271-1032 | |
Micah Spencer, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 407, Mishawaka, IN 46545 Phone: 574-335-6500 |